KT-474 OPTIONS

KT-474 Options

In reports in which cerivastatin sodium continues to be administered concomitantly with cholestyramine, no adverse reactions unique to this mixture or Along with Those people Earlier reported for this class of medication ended up noted. Myopathy and rhabdomyolysis (with or without acute renal failure) are noted when HMG-CoA reductase inhibitors are

read more